Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RIVAXA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/RIVAXA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

Approved

STANDARD

RIVAXA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

Glenmark Pharmaceuticals S.R.O.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 5, 2024
Approval ID: e61ce2c6fdbc637a
Company: Glenmark Pharmaceuticals S.R.O.
Type: Standard

Approval Details

Approval Id: e61ce2c6fdbc637a
Drug Cima Aemps Name: RIVAXA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Register Number: 89274
Holder Company Name: Glenmark Pharmaceuticals S.R.O.
Marketing Company Name: Glenmark Farmaceutica S.L.U
Holder Company Detail Path: /organization/glenmark-pharmaceuticals-s-r-o
Authorization Date: 2024-03-05
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glenmark Pharmaceuticals S.R.O.
Company Detail Path: /organization/glenmark-pharmaceuticals-s-r-o

Company Information

Pharmaceutical Company Name: Glenmark Pharmaceuticals s.r.o.
Country Name: Czech Republic
City Name: praha,hlavní město praha,country_cz
Address: Hvězdova 1716/2B

Active Ingredients

RIVAROXABAN

20 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 5, 2024

Approval ID

e61ce2c6fdbc637a

Type

Standard

Back to CIMA-AEMPS Approvals